The Proteinase K market size is USD 4.822 Bn in 2026.
The Proteinase K market is projected to grow at a CAGR of 8% by 2033.
The Proteinase K market growth drivers include rising adoption in molecular diagnostics, increasing use in point-of-care testing, and growing prevalence of chronic and infectious diseases.
North America is a dominating region for Proteinase K market.
Merck KGaA, Thermo Fisher Scientific Inc., QIAGEN N.V., Promega Corporation, and F. Hoffmann-La Roche Ltd. are some leading industry players in the Proteinase K market.